tyrosyl-isoleucyl-glycyl-seryl-arginine has been researched along with bucladesine in 1 studies
| Studies (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Trials (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Recent Studies (post-2010) (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Studies (bucladesine) | Trials (bucladesine) | Recent Studies (post-2010) (bucladesine) |
|---|---|---|---|---|---|
| 111 | 0 | 29 | 9,775 | 13 | 210 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwamoto, Y; Sugioka, Y | 1 |
1 other study(ies) available for tyrosyl-isoleucyl-glycyl-seryl-arginine and bucladesine
| Article | Year |
|---|---|
Use of a reconstituted basement membrane to study the invasiveness of tumor cells.
Topics: 1-Methyl-3-isobutylxanthine; 3T3 Cells; 8-Bromo Cyclic Adenosine Monophosphate; Amino Acid Sequence; Animals; Basement Membrane; Bucladesine; Cell Movement; Collagen; Collagenases; Culture Media, Conditioned; Depression, Chemical; Fibroblasts; Gels; Heparin; Humans; Laminin; Membrane Glycoproteins; Membranes, Artificial; Mice; Molecular Sequence Data; Neoplasm Invasiveness; Oligopeptides; Peptide Fragments; Proteoglycans; Tumor Cells, Cultured | 1992 |